May. 3 at 12:53 AM
Heads up alert! Upcoming earnings on Tuesday, 5/6/2025 for
$IQV Neutral (5.5)
In evaluating IQVIA Holdings Inc. (NYSE:IQV), the company exhibits a mixed performance profile that reflects both growth potential and recent challenges.
The P/E ratio stands at approximately 23, which is relatively in line with industry peers like Syneos Health and Parexel, suggesting that IQV is fairly valued compared to its competitors.
However, the company has recently faced a 22.2% decline in stock value over the past six months, which may raise concerns among investors regarding its stability and market sentiment.
Revenue forecasts indicate expected growth driven by its R&D Services (R&DS) and Technology & Analytics Solutions (TAS) segments, which are anticipated to bolster top-line performance for the upcoming quarter.
The company has reported a respectable EPS growth of 6.4% CAGR over the past five years, although the recent price dip could signal a need for reassessment of growth drivers.
Investors should note that IQV’s return on equity (ROE) remains strong at 23%, indicating effective management of shareholder equity.
Upcoming earnings reports are pivotal, with IQV scheduled to announce its Q1 2025 results on May 6, 2025.
Analysts are cautiously optimistic, anticipating that growth metrics in R&DS and TAS will positively impact earnings.
The consensus estimate suggests a slight increase in earnings per share, although the company has been characterized by lowered guidance in recent communications, which may temper expectations.
Historical performance shows that IQV has been able to navigate market volatility, but the recent amendments to their credit agreements and the broader market downturn may pose risks.
Analyst consensus is crucial here, as the balance between growth potential and operational challenges will significantly influence stock performance moving forward.
- Funds were net buyers of
$IQV during the previous reporting quarter.
- Top 5 funds with large holdings in
$IQV:
* Farallon Capital Management LLC
$614MM. CGMFundRank: 79%, Fund Website: www.faralloncapital.com
* Cantillon Captal Management LLC
$406MM. CGMFundRank: 66%, Fund Website: www.cantillon.com
* Holocene Advisors LP
$99MM. CGMFundRank: 79%, Fund Website: www.holoceneadvisors.com
* Cadian Capital Management LP
$79MM. New position. CGMFundRank: 88%, Fund Website: www.cadiancap.com
* Tybourne Capital Management (HK) LTD
$39MM. CGMFundRank: 62%, Fund Website: www.tybournecapital.com
- Last 10 days performance: 7%
- Last 30 days performance: -12%
- Last 90 days performance: -24%
Follow ChessGM on stocktwits.com to get timely earnings alerts. Not a financial advice. Not a trading signal.
